-
EP3086637
European procedure
Extract from the Register of European Patents
EP About this file: EP3086637
| EP3086637 - NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 08.11.2019 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 30.11.2018 | ||
| Former | Grant of patent is intended Status updated on 19.07.2018 | ||
| Former | Examination is in progress Status updated on 14.07.2017 | Most recent event Tooltip | 08.11.2019 | No opposition filed within time limit | published on 11.12.2019 [2019/50] | Applicant(s) | For all designated states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | [2016/44] | Inventor(s) | 01 /
GURER, Cagan c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | 02 /
IOFFE, Ella c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | 03 /
MUJICA, Alexander c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | 04 /
THURSTON, Gavin c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | [2016/44] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2019/01] | J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
| Former [2016/44] | Nicholls, James Ronald J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 15813960.0 | 25.11.2015 | [2016/44] | WO2015US62614 | Priority number, date | US201462087992P | 05.12.2014 Original published format: US 201462087992 P | [2016/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016089692 | Date: | 09.06.2016 | Language: | EN | [2016/23] | Type: | A1 Application with search report | No.: | EP3086637 | Date: | 02.11.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.06.2016 takes the place of the publication of the European patent application. | [2016/44] | Type: | B1 Patent specification | No.: | EP3086637 | Date: | 02.01.2019 | Language: | EN | [2019/01] | Search report(s) | International search report - published on: | EP | 09.06.2016 | Classification | IPC: | A01K67/027, C07K14/705, C07K16/28, C12N15/85, G01N33/50 | [2018/29] | CPC: |
A01K67/0278 (EP,CN,IL,KR,RU,US);
A61K49/0008 (CN,IL,RU);
A61P35/00 (EP,IL);
C07K14/4703 (EP,IL,US);
C07K14/705 (IL,US);
C07K14/70503 (CN,IL,US);
C07K14/70596 (EP,IL,KR,US);
C07K16/2803 (EP,IL,US);
C12N15/63 (US);
C12N15/8509 (IL,KR,RU,US);
G01N33/5011 (EP,IL,RU,US);
G01N33/5014 (EP,IL,RU,US);
G01N33/5055 (EP,IL,RU,US);
G01N33/5088 (EP,IL,KR,RU,US);
A01K2207/12 (IL,US);
A01K2207/15 (EP,CN,IL,KR,US);
A01K2217/05 (CN,IL);
A01K2217/052 (IL,KR,US);
A01K2217/072 (EP,IL,KR,US);
A01K2217/15 (EP,IL,KR,US);
A01K2227/105 (EP,CN,IL,KR,US);
A01K2267/03 (CN,IL);
A01K2267/0331 (EP,IL,KR,US);
A01K2267/0381 (EP,IL,KR,US);
|
| Former IPC [2016/44] | A01K67/027, G01N33/50, C07K14/705 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/44] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | NICHTHUMANE TIERE MIT HUMANISIERTEM CLUSTER DES DIFFERENZIERUNGS-47-GENS | [2016/44] | English: | NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE | [2016/44] | French: | ANIMAUX NON HUMAINS POSSÉDANT UN GÈNE CD47 HUMANISÉ | [2016/44] | Entry into regional phase | 26.07.2016 | National basic fee paid | 26.07.2016 | Designation fee(s) paid | 26.07.2016 | Examination fee paid | Examination procedure | 26.07.2016 | Examination requested [2016/44] | 24.01.2017 | Amendment by applicant (claims and/or description) | 14.07.2017 | Despatch of a communication from the examining division (Time limit: M04) | 24.11.2017 | Reply to a communication from the examining division | 05.12.2017 | Despatch of a communication from the examining division (Time limit: M04) | 27.03.2018 | Reply to a communication from the examining division | 20.07.2018 | Communication of intention to grant the patent | 23.11.2018 | Fee for grant paid | 23.11.2018 | Fee for publishing/printing paid | 23.11.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | EP18207075.5 / EP3466255 | EP20215046.2 / EP3850946 | EP23192469.7 | Opposition(s) | 03.10.2019 | No opposition filed within time limit [2019/50] | Fees paid | Renewal fee | 22.11.2017 | Renewal fee patent year 03 | 22.11.2018 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2007033221 (GEN HOSPITAL CORP [US], et al); | [Y]WO2013063556 (REGENERON PHARMA [US]); | [X]WO2013144165 (PASTEUR INSTITUT [FR]); | [XY]WO2014071397 (REGENERON PHARMA [US], et al); | [A]WO2014093678 (FRAZIER WILLIAM A [US], et al); | by applicant | US5670356 | US5874304 | US6586251 | US7294754 |